{"id":440,"date":"2020-08-04T16:37:48","date_gmt":"2020-08-04T14:37:48","guid":{"rendered":"https:\/\/www.anlegerin.at\/?post_type=encyclopedia&#038;p=440"},"modified":"2021-11-16T10:55:29","modified_gmt":"2021-11-16T09:55:29","slug":"novo-nordisk-lf","status":"publish","type":"encyclopedia","link":"https:\/\/wordpress.fobis.org\/anlegerin\/enzyklopaedie\/novo-nordisk-lf\/","title":{"rendered":"\u00b50 Novo-Nordisk (****\/WL, ETF, LGL)"},"content":{"rendered":"\r\n<p>Novo Nordisk ist Weltmarktf\u00fchrer im Insulingesch\u00e4ft. Weitere Gesch\u00e4ftsbereiche sind Blutgerinnungsmedikamente, Wachstumshormontherapie und Hormonersatztherapie.<\/p>\r\n\r\n\r\n\r\n<p><em><strong>Kaufgrund:<\/strong><\/em> Kaufempfehlung von Lisa Giering f\u00fcr langfristiges Depot, gute Bewertungen, gute Entwicklung, geringe Volatilit\u00e4t, Diversifikation<\/p>\r\n<p><em><strong>Kernkriterien f\u00fcr Bewertung:<\/strong><\/em><\/p>\r\n<ul>\r\n<li>flatex Risikoklasse: C<\/li>\r\n<\/ul>\r\n<p><em><strong>INV\/TRADE (MarketScreener):<\/strong><\/em><\/p>\r\n<ul>\r\n<li>9-10\/2021: ****\/***+<\/li>\r\n<\/ul>\r\n<p><em><strong>ESG Refinitiv (MarketScreener):<\/strong><\/em><\/p>\r\n<ul>\r\n<li>8\/2021: A-<\/li>\r\n<li>9-10\/2021: B+<\/li>\r\n<\/ul>\r\n<p><em><strong>KGV:<\/strong><\/em><\/p>\r\n<ul>\r\n<li>8\/2021: 4,8 (guidants)<\/li>\r\n<li>9\/2021: 4,7 (guidants)<\/li>\r\n<li>10\/2021: 5,0 (guidants)<\/li>\r\n<\/ul>\r\n<p><em><strong>Bestandteil von ETFs:<\/strong><\/em><\/p>\r\n<ul>\r\n<li>9-10\/2021: <a href=\"https:\/\/zw\u00f6lf.at\/anlegerin\/enzyklopaedie\/threadneedle-lux-european-select-fund-1e-eur-acc\/\" target=\"_blank\" rel=\"noreferrer noopener\">Threadneedle (Lux) &#8211; European Select Fund 1E EUR acc<\/a><\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p><em><strong>Links:<\/strong><\/em><\/p>\r\n\r\n\r\n\r\n<ul class=\"wp-block-list\">\r\n<li><a href=\"https:\/\/www.novonordisk.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Unternehmen<\/a><\/li>\r\n<li><a href=\"https:\/\/www.finanzen.net\/aktien\/novo_nordisk-aktie\" target=\"_blank\" rel=\"noreferrer noopener\">Kurs &amp; Info (finanzen.net)<\/a> \/\u00a0Kurs &amp; Info (finanzen.at)<\/li>\r\n<li><a href=\"https:\/\/de.marketscreener.com\/kurs\/aktie\/NOVO-NORDISK-A-S-1412980\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u00dcbersicht (MarketScreener)<\/a> \/ <a href=\"https:\/\/de.marketscreener.com\/kurs\/aktie\/NOVO-NORDISK-A-S-1412980\/analystenerwartungen\/\" target=\"_blank\" rel=\"noreferrer noopener\">Analyse (MarketScreener)<\/a> \/\u00a0<a href=\"https:\/\/de.marketscreener.com\/kurs\/aktie\/NOVO-NORDISK-A-S-1412980\/ratings\/\" target=\"_blank\" rel=\"noreferrer noopener\">Rating (MarketScreener)<\/a><\/li>\r\n<\/ul>\r\n\r\n\r\n\r\n<p>&nbsp;<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk ist Weltmarktf\u00fchrer im Insulingesch\u00e4ft. Weitere Gesch\u00e4ftsbereiche sind Blutgerinnungsmedikamente, Wachstumshormontherapie und Hormonersatztherapie. Kaufgrund: Kaufempfehlung von Lisa Giering f\u00fcr langfristiges Depot, gute Bewertungen, gute Entwicklung, geringe Volatilit\u00e4t, Diversifikation Kernkriterien f\u00fcr Bewertung: flatex Risikoklasse: C INV\/TRADE (MarketScreener): 9-10\/2021: ****\/***+ ESG Refinitiv&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","encyclopedia-category":[64],"encyclopedia-tag":[41],"class_list":["post-440","encyclopedia","type-encyclopedia","status-publish","hentry","encyclopedia-category-watchlist","encyclopedia-tag-204chemie"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia\/440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia"}],"about":[{"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/types\/encyclopedia"}],"author":[{"embeddable":true,"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":4,"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia\/440\/revisions"}],"predecessor-version":[{"id":2433,"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia\/440\/revisions\/2433"}],"wp:attachment":[{"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/media?parent=440"}],"wp:term":[{"taxonomy":"encyclopedia-category","embeddable":true,"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia-category?post=440"},{"taxonomy":"encyclopedia-tag","embeddable":true,"href":"https:\/\/wordpress.fobis.org\/anlegerin\/wp-json\/wp\/v2\/encyclopedia-tag?post=440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}